{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:25:03Z","timestamp":1760232303605,"version":"build-2065373602"},"reference-count":42,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>In the context of the COVID-19 pandemic, the co-circulation of influenza and SARS-CoV-2 viruses may have severe complications for vulnerable populations. For this reason, the World Health Organization pointed to the 2020\u20132021 anti-influenza campaign as being of special relevance. Our aim was to assess the 2020\u20132021 influenza vaccination coverage, and its associated factors, among patients in a Spanish multiple sclerosis (MS) unit. A cross\u2013sectional study was conducted. People attending the MS unit of the Clinical Hospital of Zaragoza during 2020 were included. Variables were obtained by reviewing records. Associations with 2020\u20132021 influenza vaccination were analyzed using bivariate analysis and a multiple logistic regression model. A total of 302 patients were studied; 62.6% were women, whose mean age (standard deviation) was 47.3 (11.5) years. The 2020\u20132021 influenza vaccination coverage was 55.3% (59.8% in women and 47.8% in men). A total of 89.7% had at least one other indication for vaccination (e.g., immunosuppressive treatment in 225 patients). The variables associated with getting vaccinated were being female (adjusted odds ratio (95% confidence interval) (aOR (95%CI) = 2.12 (1.12\u20133.99)), having received the 2019\u20132020 influenza vaccine (aOR (95%CI) = 31.82 (14.71\u201368.86)) and being born in Spain (aOR (95%CI) = 12.91 (1.07\u2013156.28)). Coverage is moderate compared to other countries. It is necessary to develop strategies to improve it, especially in men and those born outside Spain.<\/jats:p>","DOI":"10.3390\/vaccines10101766","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T11:53:55Z","timestamp":1666612435000},"page":"1766","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Influenza Vaccination among Multiple Sclerosis Patients during the COVID-19 Pandemic"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1334-6783","authenticated-orcid":false,"given":"Ignacio","family":"Hern\u00e1ndez-Garc\u00eda","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain"},{"name":"Health Services Research Group of Aragon (GRISSA), Aragon Institute for Health Research (IISA), Calle San Juan Bosco 15, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-5492","authenticated-orcid":false,"given":"Mois\u00e9s","family":"Garc\u00e9s-Redondo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Espinosa-Rueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Rodr\u00edguez-Montolio","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irantzu","family":"Bengoa-Urrengoechea","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain"},{"name":"Health Services Research Group of Aragon (GRISSA), Aragon Institute for Health Research (IISA), Calle San Juan Bosco 15, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Aibar-Rem\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain"},{"name":"Health Services Research Group of Aragon (GRISSA), Aragon Institute for Health Research (IISA), Calle San Juan Bosco 15, 50009 Zaragoza, Spain"},{"name":"Department of Preventive Medicine and Public Health, University of Zaragoza, Calle de Pedro Cerbuna 12, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022, September 15). Up to 650,000 People Die of Respiratory Diseases Linked to Seasonal Flu Each Year. Available online: https:\/\/www.who.int\/news\/item\/13-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year."},{"key":"ref_2","unstructured":"Ministerio de Sanidad (2020, December 03). Preguntas y Respuestas Sobre la Vacunaci\u00f3n Frente a la Gripe: Informaci\u00f3n Para Ciudadan\u00eda. Septiembre 2020. Available online: https:\/\/www.sanidad.gob.es\/campannas\/campanas21\/gripeYoMeVacuno.htm."},{"key":"ref_3","unstructured":"Delgado-Sanz, C., Oliva, J., Mazagatos, C., Larrauri, A., Pozo, F., and Casas, I. (2020). Informe de Vigilancia de la Gripe en Espa\u00f1a. Temporada 2019\u20132020, Instituto de Salud Carlos III. Sistema de Vigilancia de la Gripe en Espa\u00f1a."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jakimovski, D., Weinstock-Guttman, B., Ramanathan, M., Dwyer, M.G., and Zivadinov, R. (2020). Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective. Vaccines, 8.","DOI":"10.3390\/vaccines8010050"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s00415-021-10466-0","article-title":"Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: An expert consensus","volume":"268","author":"Filippi","year":"2021","journal-title":"J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017\u20132018 Influenza Season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm. Rep."},{"key":"ref_7","unstructured":"World Health Organization (2022, August 09). WHO Regional Office for Europe Recommendations on Influenza Vaccination for the 2020\/2021 Season During the Ongoing COVID-19 Pandemic (2020). Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/335721\/WHO-EURO-2020-1141-40887-55342-eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_8","first-page":"50","article-title":"Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement","volume":"36","author":"Vilella","year":"2021","journal-title":"Neurologia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1212\/WNL.0000000000008157","article-title":"Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"93","author":"Farez","year":"2019","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.msard.2019.04.004","article-title":"Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society","volume":"31","author":"Lebrun","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1352458520952310","article-title":"Vaccinations in patients with multiple sclerosis: A Delphi consensus statement","volume":"27","author":"Riva","year":"2021","journal-title":"Mult. Scler."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.vaccine.2020.12.081","article-title":"Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis","volume":"39","author":"Akmatov","year":"2021","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1212\/CPJ.0000000000001099","article-title":"Uptake and Attitudes About Immunizations in People with Multiple Sclerosis","volume":"11","author":"Marrie","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Garc\u00eda, I., Garc\u00e9s-Redondo, M., Rodr\u00edguez-Montolio, J., Bengoa-Urrengoechea, I., Espinosa-Rueda, J., Aibar-Rem\u00f3n, C., and Vaccine Working Group (2022). Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors. Vaccines, 10.","DOI":"10.3390\/vaccines10071154"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103236","DOI":"10.1016\/j.msard.2021.103236","article-title":"Vaccine hesitancy among people with multiple sclerosis","volume":"56","author":"Yap","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s13365-021-01011-w","article-title":"Influenza vaccination status in multiple sclerosis patients from Latin America","volume":"27","author":"Rojas","year":"2021","journal-title":"J. Neurovirol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ziello, A., Scavone, C., Di Battista, M.E., Salvatore, S., Di Giulio Cesare, D., Moreggia, O., Allegorico, L., Sagnelli, A., Barbato, S., and Manzo, V. (2021). Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study. Brain Sci., 11.","DOI":"10.3390\/brainsci11070890"},{"key":"ref_18","unstructured":"Ministerio de Sanidad: Vacunas y Programa de Vacunaci\u00f3n (2022, February 18). Hist\u00f3rico de Recomendaciones de Vacunaci\u00f3n Frente a la Gripe. Available online: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/gripe\/Historico_RecomendacionesVacunacion.htm."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020). The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol., 5, 536\u2013544.","DOI":"10.1038\/s41564-020-0695-z"},{"key":"ref_20","unstructured":"(2022, September 18). Heraldo de Arag\u00f3n: Cerca de 1300 Personas Tienen Esclerosis M\u00faltiple en Arag\u00f3n. Available online: https:\/\/www.heraldo.es\/noticias\/aragon\/2018\/05\/30\/cerca-300-personas-tienen-esclerosis-multiple-aragon-1246656-300.html."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: The 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jns.2011.10.013","article-title":"Seasonal and H1N1v influenza vaccines in MS: Safety and compliance","volume":"314","author":"Auriel","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/14740338.2022.2044787","article-title":"Flu vaccination in multiple sclerosis patients: A monocentric prospective vaccine-vigilance study","volume":"21","author":"Maniscalco","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_25","unstructured":"Ministerio de Sanidad (2022, May 10). Coberturas de Vacunaci\u00f3n. Datos Estad\u00edsticos. Available online: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/coberturas\/home.htm."},{"key":"ref_26","unstructured":"Centers for Disease Control and Prevention (2022, September 17). Influenza Vaccination Coverage among Health Care Personnel-United States, 2020\u20132021 Influenza Season, Available online: https:\/\/www.cdc.gov\/flu\/fluvaxview\/hcp-coverage_1920-21-estimates.htm."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dettori, M., Arghittu, A., Deiana, G., Azara, A., Masia, M.D., Palmieri, A., Spano, A.L., Serra, A., and Castiglia, P. (2021). Influenza Vaccination Strategies in Healthcare Workers: A Cohort Study (2018-2021) in an Italian University Hospital. Vaccines, 9.","DOI":"10.3390\/vaccines9090971"},{"key":"ref_28","unstructured":"Centers for Disease Control and Prevention (2022, September 19). Flu Vaccination Coverage, United States, 2020\u20132021 Influenza Season, Available online: https:\/\/www.cdc.gov\/flu\/fluvaxview\/coverage-2021estimates.htm."},{"key":"ref_29","unstructured":"Federal Statistical Office of Germany (2022, October 15). International statistics-Flu Vaccination for Senior Citizens: OECD Data for 2020 Show Substantial Increase in Vaccination Rates. Available online: https:\/\/www.destatis.de\/EN\/Themes\/Countries-Regions\/International-Statistics\/Data-Topic\/Population-Labour-Social-Issues\/Health\/Influenza-2.html."},{"key":"ref_30","unstructured":"Centers for Disease Control and Prevention (2022, September 19). Flu and Tdap Vaccination Coverage Among Pregnant Women-United States, April 2021, Available online: https:\/\/www.cdc.gov\/flu\/fluvaxview\/pregnant-women-apr2021.htm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/14760584.2021.1915776","article-title":"Vaccination coverage among health-care workers: Pre-post intervention study to assess impact of an on-site vaccination-dedicated clinic","volume":"20","author":"Papadopoli","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez, \u00c0., Soldevila, N., Toledo, D., Godoy, P., Castilla, J., Force, L., Morales, M., Mayoral, J.M., Egurrola, M., and Tamames, S. (2016). Working Group of the Project PI12\/02079. Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147931"},{"key":"ref_33","unstructured":"Garc\u00eda Calvente, M.M., del R\u00edo Lozano, M., Maroto Navarro, G., S\u00e1nchez-Cantalejo Garrido, C., and Fern\u00e1ndez Ruiz, E. (2018). Informe Salud y G\u00e9nero en Andaluc\u00eda 2018, Consejer\u00eda de Salud, Junta de Andaluc\u00eda."},{"key":"ref_34","first-page":"e201911095","article-title":"Influenza vaccination coverages and related factors among splenectomy patients from a health sector in Zaragoza (Spain)","volume":"93","year":"2019","journal-title":"Rev. Esp. Salud. Publica"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fuentes-Alonso, M., Jimenez-Garcia, R., Lopez-de-Andres, A., Zamorano-Leon, J.J., Carabantes-Alarcon, D., Jimenez-Trujillo, I., Sanz-Rojo, S., and de Miguel-Diez, J. (2022). Time Trends (2012\u20132020), Sex Differences and Predictors for Influenza Vaccination Uptake among Individuals with Chronic Obstructive Pulmonary Disease in Spain. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051423"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ruiz Azcona, L., Rom\u00e1n-Rodriguez, M., Llort Bove, M., Van Boven, J.F.M., and Santib\u00e1\u00f1ez Marguello, M. (2020). Prevalence of seasonal influenza vaccination in chronic obstructive pulmonary disease (COPD) patients in the Balearic Islands (Spain) and its effect on COPD exacerbations: A population-based retrospective cohort study. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17114027"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"27106","DOI":"10.3402\/gha.v8.27106","article-title":"Inequalities in health: Definitions, concepts, and theories","volume":"8","author":"Arcaya","year":"2015","journal-title":"Glob. Health Action"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1016\/j.vaccine.2016.10.012","article-title":"Comparison of influenza vaccination coverage between immigrant and Australian-born adults","volume":"34","author":"Karki","year":"2016","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Fabiani, M., Riccardo, F., Di Napoli, A., Gargiulo, L., Declich, S., and Petrelli, A. (2016). Differences in Influenza Vaccination Coverage between Adult Immigrants and Italian Citizens at Risk for Influenza-Related Complications: A Cross-Sectional Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166517"},{"key":"ref_40","unstructured":"Limia S\u00e1nchez, A., P\u00e9rez Mart\u00edn, J.J., Navarro Alonso, J.A., Urbiztondo Perdices, L.C., Borr\u00e0s L\u00f3pez, E., Armona Aquerreta, J.M., L\u00f3pez Hern\u00e1ndez, S., Soler Soneira, M., and de Viarce Torres de Mier, M. (2018). Vacunaci\u00f3n en Grupos de Riesgo de Todas las Edades y en Determinadas Situaciones, Ministerio de Sanidad, Consumo y Bienestar Social."},{"key":"ref_41","first-page":"1891","article-title":"Project Pi12\/02079 Working Group. Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study","volume":"12","author":"Soldevila","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Hottes, T.S., Skowronski, D.M., Hiebert, B., Janjua, N.Z., Roos, L.L., Van Caeseele, P., Law, B.J., and De Serres, G. (2011). Influenza vaccine effectiveness in the elderly based on administrative databases: Change in immunization habit as a marker for bias. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022618"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/10\/1766\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:58:42Z","timestamp":1760144322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/10\/1766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["vaccines10101766"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10101766","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}